Boao Future Hospital

date:2025-07-31

Boao Future Hospital: Pioneering a Healthier Future Through Global Medical Innovation

I. Hospital Overview

Located within the Boao Lvcheng International Medical Tourism Pilot Zone in Hainan (hereinafter referred to as the “Pilot Zone”), Boao Future Hospital serves as the core medical facility of the “International Medical Tourism Pilot Zone” jointly approved by the National Health Commission, the National Medical Products Administration, and the General Administration of Customs. It stands as China's first high-end international general hospital dedicated to the theme of “future healthcare.” Leveraging the Pilot Zone's four policy advantages—specialized medical services, research exemptions, business concessions, and international medical exchange—the hospital integrates global top-tier medical resources. Focusing on precision medicine, regenerative medicine, and intelligent diagnostics, it is committed to providing domestic and international patients with full-cycle health management services spanning prevention, diagnosis, treatment, rehabilitation, and anti-aging. Boao Future Hospital aims to become both a “testing ground for China's medical innovation” and a “global benchmark for healthcare services.”

II. Technological Advantages: Technology-Empowered, Defining the Future of Healthcare

Boao Future Hospital positions “technological innovation” as its core driver, deeply integrating cutting-edge technologies like artificial intelligence, gene editing, and cell therapy to establish a “precision diagnosis + personalized treatment” system:

• Precision Medicine Platform: Equipped with world-leading gene sequencers (e.g., Illumina NovaSeq 6000) and multi-omics analysis systems to achieve precise classification and targeted treatment for diseases such as tumors and genetic disorders;

• Regenerative Medicine Center: Incorporating Japanese iPS cell (induced pluripotent stem cell) technology and German mesenchymal stem cell preparation techniques, conducting clinical research in cartilage repair and tissue regeneration, with some technologies reaching internationally synchronized levels;

• Intelligent Diagnosis and Treatment System: Equipped with AI-assisted diagnosis platforms (e.g., IBM Watson Oncology Solution) and remote surgical robot control systems (co-developed with Johns Hopkins Hospital), enhancing surgical precision by over 40%;

• Clinical Trials for Novel Drugs and Devices: As a pioneer institution in the “Special Permit for Innovative Drugs and Devices” pilot program, it enables simultaneous access to globally unapproved innovative therapies (e.g., CAR-T cell therapy, novel targeted anticancer drugs) and high-end medical devices, prioritizing patient benefits.

III. Leading Specialties: Tackling Complex Cases, Setting Global Standards

Guided by the principle of “specialized excellence and technical precision,” the hospital prioritizes developing three world-class specialty centers while addressing comprehensive lifecycle health management needs:

1. Precision Oncology Center

Collaborating with experts from MD Anderson Cancer Center (USA) and the Cancer Hospital of the Chinese Academy of Medical Sciences, the center implements end-to-end management covering “early screening-diagnosis-treatment-follow-up.” Core technologies include:

• Liquid biopsy (early cancer screening accuracy >90%);

• Fourth-generation CAR-T cell therapy (for refractory leukemia and lymphoma);

• Proton radiotherapy (utilizing Sumitomo Heavy Industries' proton therapy system, achieving over 95% local tumor control).

2. Regenerative Medicine and Anti-Aging Center

Focusing on “cell regeneration + functional remodeling,” we provide customized anti-aging solutions:

• Stem cell anti-aging (improves skin condition, boosts immunity);

• Tissue engineering repair (joint cartilage regeneration, diabetic foot ulcer treatment);

• Hormone replacement therapy (for menopausal syndrome, hypogonadism).

3. Cardiovascular Disease Diagnosis and Treatment Center

Leveraging technical support from Stanford University's Cardiovascular Institute, we perform complex coronary interventions, atrial fibrillation radiofrequency ablation, and precision stroke prevention. Equipped with the world's first “leadless pacemaker” implantation technology and “brain-computer interface” neural rehabilitation devices.

IV. Departmental Structure: Comprehensive Health Management for All Populations

Beyond its three core specialties, the hospital operates over 20 clinical departments, including Family Medicine, Rehabilitation Medicine, Gynecology, Pediatrics, Ophthalmology, Otolaryngology, and Dentistry, to address diverse health needs across all age groups. Key departments include:

• Department of Family Medicine: Provides “one-stop” health management, integrating family doctor services, chronic disease management, and health checkups;

• Department of Rehabilitation Medicine: Incorporates Swiss RehaTech rehabilitation robots and Italian balance training systems to deliver precision rehabilitation plans for post-surgical recovery and neurological injury patients;

• International Medical Department: Tailored for expatriates with dedicated consultation areas, bilingual medical staff, privacy protection, and seamless alignment with international healthcare standards.

V. Medical Equipment: Cutting-edge global devices ensuring diagnostic precision

The hospital houses over 200 million yuan worth of imported high-end medical equipment, including several first-of-their-kind or early-adoption installations in China:

• Imaging Diagnostics: Siemens PET-MR (Positron Emission Tomography-Magnetic Resonance Imaging) from Germany; Philips Ingenia 3.0T MRI (3.0 Tesla Magnetic Resonance Imaging) from the Netherlands;

• Surgical Robots: Intuitive Surgical Da Vinci Xi (urology, general surgery), Medtronic Hugo RAS (orthopedic surgery);

• Laboratory Diagnostics: Beckman Coulter Flow Cytometer (immune function analysis), Roche Cobas 8000 fully automated biochemical/immunoassay system;

• Rehabilitation Equipment: ReWalk exoskeleton robot (aids paraplegics in standing and walking). (assisting paraplegic patients in standing and walking).

VI. International Patient Services: Seamless Care Beyond Language and Culture

Addressing international patient needs, the hospital has established a “full-chain, borderless” service system:

• Multilingual Support: Provides translation services in 10 languages, including English, Japanese, Korean, and Russian (including specialized medical translation). Medical staff hold international healthcare certifications (e.g., JCI accreditation training);

• Direct Insurance Billing: Direct payment agreements with over 50 international insurers, including Blue Cross Blue Shield USA, Japan's International Medical Welfare Organization, and Allianz Europe, eliminating upfront costs for patients;

• Visa & Accommodation Assistance: Guidance on visa-on-arrival procedures and hotel reservations (partner hotels include Lecheng Ruijin International Hospital Apartments and the Boao Forum for Asia Permanent Conference Venue Hotel);

• Remote Consultations: Enable video consultations with top-tier global hospitals like Mayo Clinic (U.S.) and The Royal Marsden (UK), allowing patients to engage directly with international specialists;

• Comprehensive Accompaniment: Dedicated customer service representatives or interpreters accompany patients throughout the entire process—from admission registration and examinations to medication pickup—ensuring privacy protection compliant with HIPAA (Health Insurance Portability and Accountability Act) standards.

VII. International Patient Testimonials: Authentic Feedback, Proving Medical Excellence

• John (Prostate Cancer Patient, USA): “Proton therapy here spared me the side effects of traditional radiation. The medical team used 3D modeling to tailor my treatment plan. My PSA levels normalized within 3 months post-treatment. Nurses check my recovery daily in English—more attentive than hospitals back home!”

• Japanese Patient Ms. Yamada (Anti-Aging Treatment): “I chose the stem cell facial rejuvenation program. After one month, my skin's firmness improved significantly. The hospital environment resembles a five-star hotel. International department staff proactively translated my medical reports and recommended local cuisine and attractions in Lecheng. It healed both my body and my spirit.”

• Russian Patient Ivan (Pediatric Congenital Heart Disease): " Through remote consultation, American specialists and Boao doctors collaboratively developed the surgical plan. The Da Vinci robot-assisted procedure left only a 2cm incision, and my child was up and walking the day after surgery. Thank you to the Chinese doctors for giving him a second chance at life!"

VIII. Contact Information, Address & Transportation Routes

Hospital Address: No. 9 Leyidao Avenue, Boao Lvcheng International Medical Tourism Pilot Zone, Qionghai City, Hainan Province (Boao Future Hospital Building)

WeChat Official Account: Search “Boao Future Hospital” for updates, appointment scheduling, and health education.

Transportation Guide:

• By Air: From Haikou Meilan International Airport, take the airport shuttle “Lecheng Pilot Zone Special Line” (approx. 1 hour, ¥30 fare) directly to the hospital; or take a taxi (approx. 40 minutes, ¥150 fare).

• High-Speed Rail: Alight at Qionghai Station. Take a taxi for about 15 minutes (approx. ¥25 fare), or board the Pilot Zone shuttle bus (one departure per hour, free of charge).

• By Car: Navigate to “Boao Future Hospital.” The hospital offers free parking (two underground levels with ample spaces).

Conclusion

Guided by the mission “Empowering Health Through Technology, Driving the Future Through Innovation,” Boao Future Hospital serves not only as a gateway for medical openness in Hainan Free Trade Port but also as the premier destination for global patients seeking precision treatment and high-quality healthcare services. Moving forward, the hospital will continue introducing cutting-edge international technologies and deepening global collaborations, contributing “Chinese wisdom” and “Boao solutions” to the cause of human health.

Document dated 2025-09-12 17:43 Modify